Hedge fund billionaire John Paulson netted $1.3 billion on an M&A deal, and Carl Icahn and Bill Ackman are "trading places" on Herbalife, reports CNBC's Kate Kelly.» Read More
Carl Icahn raised his stake in Chesapeake Energy to 7.6 percent, according to an SEC filing. In a letter to Chesapeake's board, he also asked for two board seats and that another big shareholder get two board seats.
Carl Icahn discloses a huge stake in Chesapeake Energy, reports CNBC's Kate Kelly.
Carl Icahn takes a 7.6 percent stake in Chesapeake Energy, but says the company's board faces a "substantial credibility gap," reports CNBC's Kate Kelly.
CNBC's Kate Kelly reports BlackRock is increasing its stake in Chesapeake Energy to 4 million shares from fewer than 1 million.
Does the pullback in shares of Starbucks signal a buying opportunity for investors? Jim Iuorio, TJM Institutional Services, discusses why he is short the stock. Dan Dicker, MercBloc, also weighs in on expectations that Carl Icahn will disclose a sizable stake in Chesapeake Energy.
CNBC's David Faber reports Elliot International notified BMC Software it intends to nominate a slate of five board members and billionaire investor Carl Icahn is ready to disclose his stake in Chesapeake Energy.
Jim Cramer explains what to watch ahead of the open, including expectations that billionaire Carl Icahn will take a big position in Chesapeake Energy.
Allscripts Healthcare Solutions is enacting a shareholder rights plan — or “poison pill” — to help it ward off an opportunistic takeover bid, even before an offer emerges.
CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.
Sharing perspective on how to position your portfolio if the S&P ends negative in April, with Richard Bernstein, Richard Bernstein Advisors CEO and Thomas Lee JPMorgan chief US equity strategist.
CNBC's Kayla Tausche and Tyler Mathisen discuss the latest action of activist investors, with Treasury Curve's Jeff Kilburg.
The FMHR traders discuss how eBay has led the electronic payment market. CNBC's Kayla Tausche also reports on how some of the biggest activist investors are doing now.
Should you invest alongside activist investors? CNBC's Kayla Tausche reports.
CNBC's Kate Kelly is keeping an eye on activists making a solid start this year. Donald Drapkin, Casablanca Capital chairman, also weighs in on how famous activists like Dan Loeb and Carl Icahn make money.
CNBC's Kayla Tausche reports the latest on Phil Falcone and the possibility of a LightSquared bankruptcy.
Carl Icahn, Icahn Enterprises chairman, discusses his tender offer for CVR Energy, and now holds 69% of the company's shares. Icahn also weighs in on whether Amylin Pharma should be sold, and reveals his thoughts on RIMM, with the Fast Money traders.
Carl Icahn has a simple investment philosophy, he told CNBC: Buy "underperforming" companies and "make things change." That's why he is in a fight for energy company CVR Energy.
Carl Icahn, Icahn Enterprises chairman, explains why he sold Lionsgate stock. He also offers insight on MF Global and his battle for CVR Energy.
CNBC's Gary Kaminsky has the story on whether billionaire investor Carl Icahn is the buyer behind Jefferies.
CNBC's Julia Boorstin reports that Lions Gate Entertainment expects to gross $70-$100 million at U.S. box offices for opening weekend of "The Hunger Games."